Novel EGFR-MAPK kinase and ABC transporter inhibitors for HepG2 resistant to Erlotinib

Trevor Ostlund, Kakan SutraDhar, Sara M. Elgazwi, Mater Mahnashi, Jennifer Kyeremateng, Surtaj Iram, Fathi Halaweish

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Novel EGFR-MAPK kinase and ABC transporter inhibitors for HepG2 resistant to Erlotinib'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science